PLAU and cancer: Urokinase-type plasminogen activator (PLAU), a serine protease involved in cancer metastasis29, was identified as the most significantly changed protein (Fig. 2b) and the highest scoring ligand in PCC-to-PSC paracrine signaling (Fig. 5g).